Sunnyvale, CA and Toronto, Canada 1/29/07—MDS has signed a definitive agreement to purchase Molecular Devices for $615 million in cash, or $35.50 per share, a 49% premium over the January 26 trading price. In the first 12 months, the acquisition is expected to add $190 million in revenues and $45–$50 million in EBITDA (earnings before […]
According to a report by the Statistics Bureau of Japan’s Ministry of Internal Affairs and Communications, total R&D expenditures for Japanese fiscal year (JFY) 2005 (April 1, 2005-March 31, 2006) were ¥17,845.2 billion ($156.5 billion), up 5.4% from JFY 2004. Of this, natural sciences R&D made up ¥16,472.1 billion ($144.5 billion). R&D was 3.53% of […]
Company Announcements NimbleGen Systems named Gregory McGuinness as vice president of International Business. He was previously director of European Business Development for Gene Logic. NimbleGen Systems obtained a license to the “Southern array patents” from Oxford Gene Technology (OGT) and will supply OGT with microarrays for use in its service business. Oxford Gene Technology granted […]
Pay Invoice
Latest Blogs
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.